Introduction
The study of neurodegenerative diseases began over a hundred years ago when Alois Alzheimer identified fibrillar structures within the postmortem brain of a patient who had exhibited progressive cognitive dysfunction and psychosis 1 . It is now known that the majority of neurodegenerative diseases characterized by progressive neuronal dysfunction and loss are associated with the deposition of misfolded proteins. These misfolded proteins are frequently found in a β-sheet rich fibrillar protein conformation known as amyloid 2, 3 ( Figure 1 ). For more than forty years amyloid deposits were thought to be causative agents in the degenerative process 4 . But the tables have turned. Recent studies suggest instead that a group of still poorly defined pre-amyloid species, rather than the amyloid deposits themselves, are the true toxic conformations [5] [6] [7] [8] ( Figure 1 ).
These soluble prefibrillar oligomers share conformational characteristics independent of the proteins primary amino acid sequences and may share a common mechanism of toxicity 5 . Indeed even proteins completely unrelated to disease, such as PI3 kinase and the E. Coli protein HypF-N, can be induced to form such prefibrillar structures in vitro and, when they do, they are toxic when applied extracellularly to cells in culture or injected into rat brains 9, 10 . The intra-and extracellular conversion of misfolded proteins into highly structured and less reactive amyloid forms may reduce the levels of these toxic protein species and therefore be protective.
For the purpose of this perspective, we focus on three neurodegenerative diseases, Alzheimer's, Huntington's and prion disease. We will first present studies in which the formation of inclusion bodies and amyloid plaques protects against proteotoxicity and then discuss how exceeding the cellular capacity for deposition of misfolded proteins may give rise to toxic protein species. Although these studies do not preclude detrimental effects of amyloid deposits in particular contexts (eg. obstructive vascular amyloid), they clearly show that amyloid formation can be beneficial.
Pathological features associated with neurodegenerative diseases
The protein deposits found in Alzheimer's, Huntington's and prion disease are formed by completely unrelated proteins. They accumulate in distinct brain regions and have highly characteristic morphologies that form the basis of histological diagnosis.
Neurodegeneration also affects distinct regions of the brain in each diseases, reflecting disease specific vulnerability of particular neurons 11 . However, in all three diseases the correlation between the localization of neurodegeneration and protein deposition is weak.
Alzheimer's disease (AD), the most common cause of dementia, most severely affects the temporal pole, hippocampus and amygdala 12 to the presence of a large number of florid plaques in the cerbral and cerebellar cortex 24 .
Florid plaques have a dense amyloid core, a pale radiating fibrillar periphery and are surrounded by a halo of spongiform change. Interestingly, spongiform change in variant CJD is most pronounced in the basal ganglia, which contain relatively few amyloid plaques 24 .
In summary, while the particular misfolded proteins vary in these diseases, in all three cases protein deposits are a poor indicator of neuronal loss. This makes it plausible that structured protein deposits help cells cope with misfolded proteins. In turn, the failure of particular neurons to create such deposits may cause their disease specific vulnerability.
Protein deposition as a cellular response to misfolded proteins
One of the first indications that protein inclusions may protect cells from toxic misfolded proteins came from a study investigating the response of tissue culture cells to either proteasome inhibitors or to overexpression of proteins targeted to the proteasome.
The Kopito laboratory established that exceeding the proteasome's capacity to cope with misfolded proteins, by either perturbation, leads to the accumulation of stable aggregates at a distinct structure adjacent to the centrosome 25 . This structure was termed the aggresome to emphasize that its formation is a common cellular response to the presence of aggregated misfolded protein.
The aggresome is highly structured deposit of insoluble protein surrounded by a cage formed by the intermediate filament protein vimentin. Most strikingly, aggresomes are actively formed near the centrosome through dynein-dependent retrograde transport of protein aggregates along microtubules [25] [26] [27] . Far from being amorphous protein accumulations, aggresomes are formed through an active and conserved cellular process, that appears to serve a vital purpose: sweeping the cytoplasm clear of potentially toxic aggregates of misfolded proteins 28 .
Protein deposition as a protective mechanism
A host of studies involving proteins linked to neurodegenerative diseases and other amyloidogenic proteins have investigated the role of inclusion and plaque formation in pathogenicity. The case is perhaps strongest for Huntington's disease, for which it has been postulated that inclusions cause toxicity due to the sequestration of proteins critical for cell homeostasis 29 . Indeed, inclusions formed by mutant Huntingtin protein have been shown to sequester glyceraldehydes-3-phosphate dehydrogenase, to impair transcription due to sequestration of the transcriptional coactivator CREB binding protein, and to interfere with the function of the ubiquitin-proteasome system [30] [31] [32] .
However smaller oligomeric species and loosely packed amorphous aggregates may be more prone to interact with and sequester proteins than densely packed amyloid deposits.
Indeed, several studies suggest that the formation of tightly packed Huntingtin deposits is beneficial for cell survival. The Greenberg lab demonstrated that transfection of mutant huntingtin into primary striatal neurons induced the formation of inclusions 33 .
The inclusions formed resembled protein deposits found in the brains of Huntington patients, as they were intranuclear and ubiquitinylated. But inclusions were not sufficient to induce apoptosis. On the contrary, inhibiting the ubiquitinylation of mutant Huntingtin prevented the formation of inclusions and actually increased cell death 33 .
In a complementary study, the Finkbeiner group used time-lapse microscopy to follow the fate of individual huntingtin transfected neurons. The majority of neurons died without the formation of inclusion bodies and the formation of an inclusion body actually increased the probability of neuron survival 34 . The formation of inclusion bodies directly correlated with a decrease in soluble Huntingtin, suggesting that inclusion bodies protect neurons by decreasing levels of soluble toxic isoforms of Huntingtin 34 . Inclusion body formation could also serve a protective function by increasing the autophagic degradation of the aggregated protein species 35 . Inclusions of mutant Huntingtin directly induce autophagy through sequestration of mTOR, a negative regulator of autophagy, and autophagy not only reduces the levels of aggregated but also soluble mutant huntingtin 36, 37 .
Together, these studies suggest that compounds elevating the formation of inclusion bodies, such as aggresomes, could lessen cellular pathology. On the other hand compounds antagonizing the toxicity of mutant huntingtin by reducing its aggregation have been identified 38 . On the surface, this appears to conflict with the notion that promoting inclusions may be beneficial, but both, solubilization and inclusion body formation, may diminish the levels of toxic oligomers, the more critical species in pathogenesis. In fact, in a HD model a compound could prevent huntingtin-mediated proteasome dysfunction by promoting inclusion formation 39 .
Although the characteristic protein deposits are found extracellularly in AD and prion disease, not intracellularly as in HD, here too studies suggest that structured protein deposits are less toxic than other conformers. As for HD, amyloid assembly may serve a beneficial function by shifting the equilibrium away from more toxic conformers, such as prefibrillar oligomers 5, 6, 8 .
In In a separate study by the Mucke group, a point mutation within Aβ, the Arctic mutation (Aβ E22G), influenced the rate at which Aβ assembled into amyloid fibers. In vitro and in transgenic mice, the Artic mutation enhanced formation of neuritic amyloid plaques and diminished non-amyloid Aβ assemblies 41 . As non-amyloid Aβ assemblies correlated with behavioral and neuronal deficits in these transgenic mice, the promotion of Aβ amyloid fibril formation, without a coinciding increase in oligomeric Aβ, may be beneficial.
Most recently, in a follow-up study of a clinical trial, the immunization of AD patients with the full length Aβ peptide exhibited reduced Aβ immunostaining and amyloid plaques 42 . Unfortunately, immunization neither slowed nor stopped the progression of neurodegeneration. We recently reported that moderate ectopic overexpression of Rnq1 is extremely However, when the mutant huntingtin formed scattered secondary inclusions, the completion of mitosis was delayed or even failed completely 57 . The Kampinga group speculated that these secondary inclusions, distinct from aggresomes, form when the process of aggresome formation is saturated 57 . These results are reminiscent of our studies in which overexpression of the yeast prion protein Rnq1 resulted in toxicity when it exceeded the cellular capacity to efficiently assemble the prion protein into amyloid. hypothesize that this process can also result in the formation of toxic protein species. We refer to this as non-productive templating, which occurs when the cellular capacity to facilitate amyloid formation is exceeded or impeded (Figure 2 ).
The notion of non-productive templating offers a unifying explanation for the observation that amyloid formation is sometimes associated with toxicity even when the amyloid form itself is benign. We discuss two cases in point: As mentioned earlier, the expression of GPI-anchorless PrP resulted in the formation of amyloid plaques but was not overtly toxic. However, when GPI-anchorless PrP was expressed together with WT PrP, deposits of both amyloid and non-amyloid PrPres formed and the clinical manifestations of scrapie disease were enhanced 44 . It has been suggested that PrPres subverts a stress protective function of PrP into an apoptotic signal 59 . The toxic signal elicited is dependent on the presence of PrPres and the expression of GPI-anchored PrP 59 .
PrPres may influence the folding state of the GPI-anchored PrP through incomplete templating and thus cause the induction of a toxic signal. Amyloid fibrils grow by causing protein of the same amino-acid sequence to adopt the same amyloid conformation. This is referred to as amyloid templating and involves the efficient addition of monomer or oligomeric species to the amyloid fiber, which maybe assisted by specific chaperones (e.g. Rnq1 and the Hsp40 Sis1, Sup35NM and Hsp104 49 ).
If the amount of substrate exceeds the cellular capacity for amyloid conversion or if amino acid sequences are incompatible, the interaction with the amyloid fibrils may give rise to other abnormal conformational species, which may go on to form toxic oligomers and amorphous aggregates (Rnq1, PrP and Het-s/S). We refer to this as non-productive templating.
